NCT00564031View on ClinicalTrials.gov

Hormonal Replacement Therapy and Small Artery Function

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

August 31, 2004

Conditions
Menopause
Interventions
DRUG

Femanest

2mg/day

DRUG

gestapuran

5mg/day

DRUG

placebo

daily

DRUG

Femanest plus Gestapuran

combined daily

Trial Locations (1)

14186

Karolinska University hospital-huddinge, Stockholm

All Listed Sponsors
lead

Karolinska University Hospital

OTHER

NCT00564031 - Hormonal Replacement Therapy and Small Artery Function | Biotech Hunter | Biotech Hunter